SIZE AND TIMING OF LOCAL RECURRENCE PREDICTS METASTASIS IN SOFT-TISSUE SARCOMA - GROWTH-RATE INDEX RETROSPECTIVELY ANALYZED IN 134 PATIENTS

被引:17
作者
CHOONG, PFM [1 ]
GUSTAFSON, P [1 ]
RYDHOLM, A [1 ]
机构
[1] UNIV LUND HOSP, DEPT ORTHOPED, S-22185 LUND, SWEDEN
来源
ACTA ORTHOPAEDICA SCANDINAVICA | 1995年 / 66卷 / 02期
关键词
D O I
10.3109/17453679508995509
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Our study combined size and timing of the first local recurrence to create a growth rate index (GRI - ratio of size (cm) to timing (mo)) which we analyzed for an association with metastasis. We analyzed 134 locally recurrent tumors from a series of 460 adult patients with soft tissue sarcoma of the extremities and trunk wall who were diagnosed and treated between 1964 and 1990, with a median follow-up of 10 (2-28) years for survivors. None of the patients had metastases at diagnosis. One half (74) of local recurrences were from inadequately treated primaries, one half (71) were associated with metastases, and two thirds (89) were seen in non-center-treated patients. There were equal numbers of patients with GRI less than or equal to 0.4 (low) and > 0.4 (high). Patients with a low GRI had a better 2-year metastasis-free survival (80 percent) than those with a high GRI (30 percent). High GRIs were associated with large, high grade primary tumors and a short metastasis-free interval in comparison to low GRI tumors. Time to local recurrence strongly correlated with the time to metastasis (R(2) 0.85, p < 0.001). GRI was a good discriminator of metastasis in patients with tumors larger than 5 cm and of malignancy grade IV. Our study suggests that clinical characteristics (e.g., GRI) of local recurrence rather than presence, per se, are important in predicting tumor behavior.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 16 条
[1]   ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN IN HIGH-GRADE SOFT-TISSUE SARCOMA - A RANDOMIZED TRIAL OF THE SCANDINAVIAN-SARCOMA-GROUP [J].
ALVEGARD, TA ;
SIGURDSSON, H ;
MOURIDSEN, H ;
SOLHEIM, O ;
UNSGAARD, B ;
RINGBORG, U ;
DAHL, O ;
NORDENTOFT, AM ;
BLOMQVIST, C ;
RYDHOLM, A ;
STENER, B ;
RANSTAM, J .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1504-1513
[2]  
ANGERVALL L, 1986, SEMIN DIAGN PATHOL, V3, P240
[3]  
ENNEKING WF, 1980, CLIN ORTHOP RELAT R, V153, P106
[4]  
Enzinger FM, 1988, SOFT TISSUE TUMORS, P201
[5]  
GUSTAFSON P, 1991, CANCER, V67, P2083, DOI 10.1002/1097-0142(19910415)67:8<2083::AID-CNCR2820670813>3.0.CO
[6]  
2-5
[7]   METASTASIS-FREE SURVIVAL AFTER LOCAL RECURRENCE OF SOFT-TISSUE SARCOMA [J].
GUSTAFSON, P ;
DREINHOFER, KE ;
RYDHOLM, A .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1993, 75 (04) :658-660
[8]  
GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1
[9]   ADULT SOFT-TISSUE SARCOMAS - A PATTERN OF CARE SURVEY OF THE AMERICAN-COLLEGE-OF-SURGEONS [J].
LAWRENCE, W ;
DONEGAN, WL ;
NATARAJAN, N ;
METTLIN, C ;
BEART, R ;
WINCHESTER, D .
ANNALS OF SURGERY, 1987, 205 (04) :349-359
[10]  
MARKHEDE G, 1982, CANCER, V48, P1721, DOI 10.1002/1097-0142(19820415)49:8<1721::AID-CNCR2820490832>3.0.CO